Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Track record
Movers
The Lead Compound
Home
›
Targets
› MICA/B
MICA/B
(1 companies · 2 programs)
Companies with an active program directed at MICA/B.
FATE THERAPEUTICS INC
FATE
FT836
— Solid Tumors
Phase 1
FT836
— Multiple Myeloma
Preclinical